Johnson & Johnson Logo

Johnson & Johnson

🇺🇸
JNJ
US4781601046

Johnson & Johnson is a leading US-based global healthcare company focused on developing and providing innovative pharmaceuticals and medical technology solutions. The company is dedicated to advancing global human health, sustainably optimizing patient lives, and enhancing quality of life through its cutting-edge products and therapies.

Next Quarterly Earnings

Tuesday, October 20, 2026
CW 43
Pre-Market
In 54 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on September 22, 2026

Stock Price

Recap: the latest results

Johnson & Johnson (JNJ) reported its Q2 2026 results on July 15, 2026, before market open. The company reported an EPS of 2.90 USD, beating the analyst estimate of 2.85 USD by 1.6%. Revenue reached 25310 million USD for the quarter. Following the release, the stock price decreased by 2.69%.

Generated automatically from our data — as of 07/23/2026 Read the article →

Frequently asked questions

When will Johnson & Johnson report its next quarterly earnings?

Johnson & Johnson is scheduled to report its next quarterly earnings on 10/20/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Johnson & Johnson last report quarterly earnings?

Johnson & Johnson last reported quarterly earnings on 7/15/2026 (Q2 2026). Earnings per share (EPS) came in at 2.90 USD.

How does Johnson & Johnson stock react to earnings?

Across its last 5 earnings reports, Johnson & Johnson stock moved by ±1.1% on average the following day. The largest reaction was -2.7% on 07/15/2026; 1 of 5 reactions were positive.

How often has Johnson & Johnson beaten expectations?

Johnson & Johnson has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Johnson & Johnson earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$2.90
Actual:
Q2 2026
Beat
Estimate:$2.85
Actual:$2.90
Difference:+$0.05
Price reaction (1 day):-2.7 %
Price reaction (7 days):+0.7 %
Q1 2026
Beat
Estimate:$2.68
Actual:$2.70
Difference:+$0.02
Price reaction (1 day):+0.9 %
Price reaction (7 days):-5.0 %
Q4 2025
Missed
Estimate:$2.46
Actual:$2.46
Difference:-$0.00
Price reaction (1 day):-0.1 %
Price reaction (7 days):+4.4 %
Q3 2025
Beat
Estimate:$2.76
Actual:$2.80
Difference:+$0.04
Price reaction (1 day):0.0 %
Price reaction (7 days):+0.5 %
Q1 2025
Beat
Estimate:$2.68
Actual:$2.77
Difference:+$0.09
Q4 2024
Estimate:
Actual:
Price reaction (1 day):-1.9 %
Price reaction (7 days):+2.0 %

Earnings statistics

Stock reaction to earnings

±1.1%
Avg. next-day move
-2.7%
Largest move (07/15/2026)
20%
Share of positive reactions
±2.5%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+0.5%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Johnson & Johnson
Ticker Symbol
JNJ
ISIN
US4781601046
Country
🇺🇸
USA
Sector
Index membership